(Q43997685)

English

A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: a Southwest Oncology Group Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: a Southwest Oncology Group Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

author name string

B L Zidar

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

S Green

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

H I Pierce

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

R W Roach

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

S P Balcerzak

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

L Militello

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 September 1988

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

223-226

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

https://scigraph.springernature.com/pub.10.1007/bf00175403

0 references

Phase II trial of high-dose cisplatin in patients with malignant mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3192388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of six cases of mesothelioma with doxorubicin and cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3192388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracavitary cisplatin chemotherapy for mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3192388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3192388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3192388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00175403

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43997685&oldid=2105521316"